Swiss drug maker Novartis to acquire AveXis for $8.7b

Swiss drug maker Novartis to acquire AveXis for $8.7b

A Novartis logo is pictured on its headquarters building in Mumbai April 1, 2013. REUTERS/Vivek Prakash/File Photo

Naomi Kresge, Phil Serafino

09 April, 2018

avexis inc GSK Novartis

Printed by Unregistered user on Mon, 08 Dec 2025 01:47:11 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

Read more from World

National Storage REIT agrees to $2.65b buyout by Brookfield–GIC consortium

Netflix to buy Warner Bros Discovery’s studios, streaming unit for $72b